Yutaka Ishida Selected Research

Hydroxyzine (Vistaril)

9/2009

[Tendencies of prescriptions for neuralgic pain in National Suruga Sanatorium (leprosy), Japan during last 11 years].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yutaka Ishida Research Topics

Disease

5	Leprosy (Hansen's Disease) 12/2014 - 09/2006
2	Erythema Nodosum 12/2014 - 09/2011
2	Congenital Abnormalities (Deformity) 12/2013 - 09/2006
1	COVID-19 01/2022
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Cytopenia 01/2020
1	Lupus Nephritis 01/2016
1	Ulcerative Colitis 01/2016
1	Rheumatoid Arthritis 01/2016
1	Lymphoma (Lymphomas) 01/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016
1	Ankylosing Spondylitis 01/2016
1	Multiple Myeloma 09/2011
1	Neuralgia (Stump Neuralgia) 09/2009
1	Pain (Aches) 09/2009
1	Periodontal Diseases (Periodontal Disease) 06/2008
1	Foot Ulcer 09/2007

Drug/Important Bio-Agent (IBA)

2	Thalidomide (Thalomid)FDA Link 12/2014 - 09/2011
2	Dapsone FDA Link 12/2013 - 09/2006
2	Rifampin (Rifampicin)FDA LinkGeneric 12/2013 - 09/2006
2	SteroidsIBA 09/2011 - 09/2009
1	AntibodiesIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2014
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2009
1	Pentazocine (Talwin)FDA LinkGeneric 09/2009
1	loxoprofen (CS 600)IBA 09/2009
1	Prednisolone (Predate)FDA LinkGeneric 09/2009
1	Hydroxyzine (Vistaril)FDA LinkGeneric 09/2009
1	Cysteine Proteases (Cysteine Protease)IBA 06/2008
1	Gingipain Cysteine EndopeptidasesIBA 06/2008
1	Lysine (L-Lysine)FDA Link 06/2008
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 09/2007

Therapy/Procedure

4	Therapeutics 01/2020 - 09/2006